Sign in Subscribe

Analysis

In-depth editorial on the forces shaping biotech and pharma markets.
20
Apr
Gene therapy’s quiet pivot to precision

Gene therapy’s quiet pivot to precision

A six-week data snapshot shows clinical activity building where press attention isn’t - three companies, thirteen trials, and fifteen orphan designations.
3 min read
01
Apr
Lilly, Novo, and the new terms of the oral obesity market

Lilly, Novo, and the new terms of the oral obesity market

Orforglipron outperformed Rybelsus on every efficacy measure. The discontinuation rate is the number that matters now.
2 min read